Cargando…
In Reply: Telotristat Ethyl for Patients With Carcinoid Syndrome Associated With Chest Pain and Hypertension
Autores principales: | Jiang, Wenjun, Perez-Olle, Raul, Lapuerta, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143199/ https://www.ncbi.nlm.nih.gov/pubmed/30153219 http://dx.doi.org/10.1097/MPA.0000000000001138 |
Ejemplares similares
-
Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome
por: Metz, David C, et al.
Publicado: (2020) -
TELEPRO: Patient‐Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World
por: Strosberg, Jonathan, et al.
Publicado: (2019) -
Telotristat ethyl for carcinoid syndrome diarrhoea
Publicado: (2019) -
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial
por: Pavel, Marianne, et al.
Publicado: (2018) -
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome
por: Dillon, Joseph S., et al.
Publicado: (2020)